In a post on Foreign Policy’s “Passport” blog, assistant managing editor Elizabeth Dickinson looks at the potential ramifications of a recent study, which found that early antiretroviral treatment in HIV-positive people can prevent transmission by 96 percent.
“Health officials on Monday celebrated a faster treatment for people who have tuberculosis but aren’t infectious, after investigators found a new combination of pills knocks out the disease in three months instead of nine,” the Associated Press/Seattle Times reports (Stobbe, 5/16).
In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, “The evidence is clearly starting to show that it’s much better to treat patients earlier, but from where will the money come?”
U.S. Ambassador to Uganda Jerry Lanier on Friday in Kampala launched a Mobile Medical Male Circumcision clinic, a project of the PEPFAR-supported Makerere University Walter Reed Project (MUWRP), New Vision reports.
Legislation that criminalizes homosexual acts in Uganda did not make it to the floor of the country’s Parliament on Friday, meaning “the bill is essentially dead, for the moment,” PRI’s “The World” reports (Porter, 5/13).
Scientific American looks at the possible link between HIV prevalence and a recent increase in the number of children dying from measles in sub-Saharan Africa.
IRIN/Plus News reports that “[t]he Kenyan government and rights groups have expressed outrage at a project in western Kenya that is paying HIV-positive women to undergo long-term contraception.”
The Clinton Health Access Initiative, founded by former President Bill Clinton, with funding from the Bill & Melinda Gates Foundation and the U.K. government, has hired former pharmaceutical company scientists “to tinker with the chemistry used to synthesize a key [HIV] drug, tenofovir, reducing the cost of manufacturing,” the Wall Street Journal reports.
Results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday “[i]n what is being hailed as a breakthrough in HIV prevention,” the Los Angeles Times reports (Maugh, 5/13).
Lessons Learned About Global Health From 30 Years Of HIV/AIDS: In the CDC’s Emerging Infectious DiseasesÂ (.pdf) journal, Kevin De Cock of the CDC, Harold Jaffe of Emory University and James Curran of the Emory Center for AIDS Research reflect on the emergence of HIV/AIDS 30 years ago this June; the…